Breaking News Instant updates and real-time market news.

ALGN

Align Technology

$273.19

-4.34 (-1.56%)

13:15
12/02/19
12/02
13:15
12/02/19
13:15

Align Technology put volume heavy and directionally bearish

Bearish flow noted in Align Technology with 1,594 puts trading, or 1.1x expected. Most active are 12/6 weekly 270 puts and May-20 250 puts, with total volume in those strikes near 590 contracts. The Put/Call Ratio is 1.82, while ATM IV is up nearly 2 points on the day. Earnings are expected on January 28th.

  • 05

    Dec

ALGN Align Technology
$273.19

-4.34 (-1.56%)

10/23/19
NRCS
10/23/19
NO CHANGE
Target $299
NRCS
Buy
Northcoast analysis shows favorable utilization trends for Align's Invisalign
Northcoast analyst David Keiser says that despite a more competitive clear aligner market, his North American Invisalign doctor analysis suggests favorable utilization trends have continued. 13 additional Invisalign doctors in the analyst's sample size reached the four upper tiers of Align Technology's Invisalign Advantage Program, and he also saw a sequential increase of 85 Invisalign doctors in the Silver level of the Invisalign Advantage program. Keiser maintains a Q3 earnings per share estimate of $1.16 for Align Technology, which is 2c ahead of consensus. He reiterates a Buy rating on the shares with a $299 price target.
10/24/19
PIPR
10/24/19
NO CHANGE
Target $240
PIPR
Overweight
Align Technology reported a 'strong' quarter, says Piper Jaffray
Align Technology last night delivered a strong quarter beating on both the top and bottom lines, Piper Jaffray analyst Matt O'Brien tells investors in a research note. While the company's North American performance was solid, the standout was international as strength in Asia Pacific, driven by Japan and China, lead to a beat, says the analyst. He believes Align has the best products in the clear aligner market and that its investment into the business "should translate into healthy growth in the coming years." O'Brien reiterates an Overweight rating on Align Technology with a $240 price target.
10/24/19
STFL
10/24/19
NO CHANGE
Target $290
STFL
Buy
Align Technology results met investors' raised expectations, says Stifel
Stifel analyst Jonathan Block said the bar for Align Technology "had crept a bit higher" over the past couple of weeks, but he believes the company's Q3 results met investors' increased expectations. He also believes further upside exists "if investors get increasingly comfortable" that Align can grow revenue by 20% over the next 12-24 months while expanding its margins. Block keeps a Buy rating and $290 price target on Align Technology shares.
11/18/19
STFL
11/18/19
NO CHANGE
Target $305
STFL
Buy
Align Technology price target raised to $305 from $290 at Stifel
Following his attendance at the 2019 GP Summit, as well as Align Technology's separate analyst day meeting on Friday afternoon, Stifel analyst Jonathan Block raised his price target on the stock to $305 from $290 as he says the company highlighted the way that digital has transformed the clear aligner market while focusing on their superior digital platform, robust set of new products and plans to better penetrate the lower acuity market. Align is "highly confident" they have the best overall platform and see other alternatives as 5-10 years behind, Block noted.

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

, AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

07:46
12/13/19
12/13
07:46
12/13/19
07:46
Upgrade
Charles Schwab, TD Ameritrade, E-Trade rating change  »

Charles Schwab upgraded…

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

ETFC

E-Trade

$46.01

1.08 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 26

    Feb

07:45
12/13/19
12/13
07:45
12/13/19
07:45
General news
Treasury Market Outlook: it's rally time in equities »

Treasury Market Outlook:…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

, EHTH

eHealth

$93.74

0.89 (0.96%)

07:44
12/13/19
12/13
07:44
12/13/19
07:44
Recommendations
Health Insurance Innovations, eHealth analyst commentary  »

Health Insurance…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

EHTH

eHealth

$93.74

0.89 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$63.96

1.565 (2.51%)

07:43
12/13/19
12/13
07:43
12/13/19
07:43
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

07:42
12/13/19
12/13
07:42
12/13/19
07:42
Downgrade
Federated Investors rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$41.65

0.89 (2.18%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Recommendations
Oracle analyst commentary  »

Oracle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPI

Office Properties

$32.93

-1.02 (-3.00%)

07:37
12/13/19
12/13
07:37
12/13/19
07:37
Downgrade
Office Properties rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THTX

Theratechnologies

$3.05

-0.01 (-0.33%)

07:36
12/13/19
12/13
07:36
12/13/19
07:36
Hot Stocks
Theratechnologies reports results from in vitro, in vivo experiments on TH-1902 »

Theratechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$42.61

1.07 (2.58%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Upgrade
Hancock Whitney rating change  »

Hancock Whitney upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.44

0.46 (4.19%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

GE

General Electric

$11.44

0.46 (4.19%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Jan

NPO

EnPro

$66.48

2.53 (3.96%)

07:34
12/13/19
12/13
07:34
12/13/19
07:34
Conference/Events
EnPro to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.